Breast Cancer Treatment Decreases Serum Levels of TGF-β1, VEGFR2, and TIMP-2 Compared to Healthy Volunteers: Significance for Therapeutic Outcomes?

Breast Cancer Treatment Decreases Serum Levels of TGF-β1, VEGFR2, and TIMP-2 Compared to Healthy Volunteers: Significance for Therapeutic Outcomes?

Various complications from a breast cancer treatment, in the pathogenesis of which excessive tissue fibrosis plays a leading role, are a common pathology. In this study, the levels of TGF-β1, VEGFR-2, and TIMP-2 were determined by the immuno-enzyme serum analysis for patients during the long-term pe...

Full description

Bibliographic Details
Main Authors: Varvara Krasnikova, Maria Pospelova, Olga Fionik, Tatyana Alekseeva, Konstantin Samochernykh, Nataliya Ivanova, Nikita Trofimov, Tatyana Vavilova, Elena Vasilieva, Albina Makhanova, Samwel Tonyan, Alexandra Nikolaeva, Evgeniya Kayumova, Maxim Shevtsov
Format: Article
Language:English
Published: MDPI AG 2022-09-01
Series:Pathophysiology
Subjects:
breast cancer survivors
post-mastectomy pain syndrome
breast cancer
fibrosis molecules
TGF-β1
VEGFR2
Online Access:https://www.mdpi.com/1873-149X/29/3/42

Internet

https://www.mdpi.com/1873-149X/29/3/42

Similar Items